Structure of the Mycobacterial ESX-5 Type VII Secretion System Membrane Complex by Single-particle Analysis
Overview
Parasitology
Authors
Affiliations
Mycobacteria are characterized by their impermeable outer membrane, which is rich in mycolic acids. To transport substrates across this complex cell envelope, mycobacteria rely on type VII (also known as ESX) secretion systems. In Mycobacterium tuberculosis, these ESX systems are essential for growth and full virulence and therefore represent an attractive target for anti-tuberculosis drugs. However, the molecular details underlying type VII secretion are largely unknown, due to a lack of structural information. Here, we report the molecular architecture of the ESX-5 membrane complex from Mycobacterium xenopi determined at 13 Å resolution by electron microscopy. The four core proteins of the ESX-5 complex (EccB, EccC, EccD and EccE) assemble with equimolar stoichiometry into an oligomeric assembly that displays six-fold symmetry. This membrane-associated complex seems to be embedded exclusively in the inner membrane, which indicates that additional components are required to translocate substrates across the mycobacterial outer membrane. Furthermore, the extended cytosolic domains of the EccC ATPase, which interact with secretion effectors, are highly flexible, suggesting an as yet unseen mode of substrate interaction. Comparison of our results with known structures of other bacterial secretion systems demonstrates that the architecture of type VII secretion system is fundamentally different, suggesting an alternative secretion mechanism.
Multiple variants of the type VII secretion system in Gram-positive bacteria.
Garrett S, Higginson A, Palmer T Microlife. 2024; 5:uqae013.
PMID: 38957458 PMC: 11217815. DOI: 10.1093/femsml/uqae013.
Evolution and emergence of Mycobacterium tuberculosis.
Orgeur M, Sous C, Madacki J, Brosch R FEMS Microbiol Rev. 2024; 48(2).
PMID: 38365982 PMC: 10906988. DOI: 10.1093/femsre/fuae006.
A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against challenge.
Stylianou E, Pinpathomrat N, Sampson O, Richard A, Korompis M, McShane H Front Immunol. 2023; 14:1263457.
PMID: 37869008 PMC: 10585038. DOI: 10.3389/fimmu.2023.1263457.
Bunduc C, Ding Y, Kuijl C, Marlovits T, Bitter W, Houben E mSphere. 2023; 8(5):e0040223.
PMID: 37747201 PMC: 10597459. DOI: 10.1128/msphere.00402-23.
A novel variant of the type VII secretion system EssC component is associated with an Rhs toxin.
Bowran K, Garrett S, Van Vliet A, Palmer T Microb Genom. 2023; 9(6).
PMID: 37278699 PMC: 10327511. DOI: 10.1099/mgen.0.001036.